Product Name: Anti-BCL10 (MALT-Lymphoma Marker) Antibody
Description: BCL10, with an N-terminal caspase recruitment domain (CARD), is found in a number of apoptotic regulatory molecules. It was identified through its direct involvement in t(1;14) of mucosa-associated lymphoid tissue (MALT) lymphoma. Expression of BCL10 was
Target:
Conjugate:
Product Category: Mouse Monoclonal Antibody
Immunogen: Human BCL10 recombinant protein (epitope aa122-168)
Host:
Isotype: IgG1, kappa
Form:
CAS NO: 183552-38-7
Product: Abarelix
Applications: Flow Cytometry (0.5-1ug/million cells in 0.1ml)Immunofluorescence (1-2ug/ml)Western Blotting (0.5-1ug/ml)Immunohistology (Formalin-fixed) (0.5-1ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate
Reactivity: Human. Others not known.
Working Dilution:
Concentration: 0.2mg/ml
Storage: Can be stored at +4C. For long term storage, aliquot and store at -20C. Avoid repeated freezing and thawing cycles.
Species:
Synonyms: B-cell CLL/lymphoma 10, B-cell leukemia/lymphoma 10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, caspase-recruiting domain-containing protein, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN
Background:
Molecular Weight: 33kDa
Purity:
Image Description:
PubMed ID:http://aac.asm.org/content/44/2/294.abstract
HIV gp120-CD4 gp120-cd4.com
Just another WordPress site
